Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Forty Seven	Cambrex	Heron Therapeutics	Eidos Therapeutics	Xencor
Symbol	NASDAQ:FTSV	NYSE:CBM	NASDAQ:HRTX	NASDAQ:EIDX	NASDAQ:XNCR
Price Information
Current Price	$95.51	$59.99	$13.55	$41.97	$28.22
52 Week Range	Hold	Hold	Buy	Buy	Buy
Analyst Ratings
Consensus Recommendation	Hold	Hold	Buy	Buy	Buy
Consensus Price Target	$65.95	$54.75	$44.00	$60.00	$44.50
% Upside from Price Target	-30.95% downside	-8.73% downside	224.72% upside	42.96% upside	57.69% upside
Trade Information
Market Cap	$4.60 billion	$2.02 billion	$1.18 billion	$1.53 billion	$1.65 billion
Beta	0.4	2.14	1.48	-0.11	1.25
Average Volume	1,645,254	218,726	1,393,286	126,052	407,361
Sales & Book Value
Annual Revenue	$15.68 million	$532.09 million	$145.97 million	$26.69 million	$156.70 million
Price / Sales	293.35	3.80	8.39	60.56	10.26
Cashflow	N/A	$3.91 per share	N/A	N/A	$0.50 per share
Price / Cash	N/A	15.36	N/A	N/A	56.24
Book Value	$7.52 per share	$19.48 per share	$4.48 per share	$4.57 per share	$10.46 per share
Price / Book	12.70	3.08	3.02	9.18	2.70
Profitability
Net Income	$-87,620,000.00	$92.41 million	$-204,750,000.00	$-37,830,000.00	$26.88 million
EPS	($2.34)	$2.77	($2.50)	($1.03)	$0.46
Trailing P/E Ratio	N/A	21.66	N/A	N/A	62.71
Forward P/E Ratio	N/A	∞	N/A	N/A	N/A
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	N/A	5.96%	-140.27%	N/A	17.15%
Return on Equity (ROE)	-50.38%	5.38%	-61.74%	-24.75%	4.23%
Return on Assets (ROA)	-44.35%	2.50%	-46.71%	-22.41%	3.74%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	N/A	0.76%	0.03%	0.12%	0.01%
Current Ratio	14.81%	2.37%	4.95%	18.78%	8.39%
Quick Ratio	14.81%	1.70%	4.70%	18.78%	8.39%
Ownership Information
Institutional Ownership Percentage	71.77%	90.96%	N/A	31.33%	93.72%
Insider Ownership Percentage	37.40%	1.41%	12.56%	70.10%	4.33%
Miscellaneous
Employees	57	1,732	198	28	156
Shares Outstanding	48.16 million	33.72 million	90.37 million	38.51 million	56.94 million
Next Earnings Date	5/11/2020 (Estimated)	N/A	5/14/2020 (Estimated)	5/5/2020 (Estimated)	5/14/2020 (Estimated)
Optionable	Not Optionable	Optionable	Optionable	Not Optionable	Optionable

Comparison Ideas:

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

Start Your Free Trial Today

Market Data and Calendars

Investing Education and Resources